CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- 4 Option exercise SVP, CFO acquired 1,583 shares (option exercise)
- 4/A Insider Changes in Ownership
- 4 Option exercise President and CEO acquired 9,582 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Option exercise President and CEO acquired 4,791 shares (option exercise)
- 4 Option exercise CFO acquired 1,834 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 298 shares (option exercise)
- 4 Option exercise SVP, GC and Corporate Affairs acquired 1,833 shares (option exercise)
- 4 Option exercise Director acquired 298 shares (option exercise)
- 4 Open-market buy Director bought 714 shares at $0.91 ($650)
Page 5 of 14 · 265 filings